| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Gault Cheryl | Chief Operating Officer | RAPPORT THERAPEUTICS, INC., 99 HIGH STREET, SUITE 2100, BOSTON | /s/ Troy Ignelzi, Attorney-in-Fact | 09 Mar 2026 | 0001839046 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RAPP | Common Stock | Sale | $58,265 | -2,014 | -1.2% | $28.93 | 169,914 | 05 Mar 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.34 to $28.94. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |